Drug · DIN 02530864
TEVA-LENALIDOMIDE
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since May 24, 2023.
- Drug Identification Number (DIN)
- 02530864
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Lenalidomide L04AX04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LENALIDOMIDE (LENALIDOMIDE HYDROCHLORIDE MONOHYDRATE) | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 22, 2022: NOC 29035Abbreviated New Drug Submission (ANDS)
Other DINs named TEVA-LENALIDOMIDE
- DIN 02530872 · Cancelled Pre Market
- DIN 02530880 · Cancelled Pre Market
- DIN 02530899 · Cancelled Pre Market
- DIN 02530902 · Cancelled Pre Market
- DIN 02530910 · Cancelled Pre Market